Novartis AG CEO Vas Narasimhan said the company saw a very good performance across both established medicines and recent drug launches in the first quarter. He speaks with Bloomberg's Guy Johnson, Kriti Gupta, and Anna Edwards

Bank of America CEO Brian Moynihan Talks Credit Card Cap
15:03

BlackRock CEO Larry Fink Talks AI Bubbles
12:04

US Commerce Secretary Howard Lutnick Talks Trump Tariffs, Trade Relations, China
15:27